Finally, independent validation of the data on ER and HER2 expression presented is necessary in order to prove the association between low‐ and intermediate‐grade DCIS and IHC ER positivity and HER2 negativity. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.